Navigation Links
Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
Date:4/2/2009

SAN DIEGO, April 2 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today released the following letter from its Lead Independent Director, James N. Wilson, providing shareholders with an update on recent developments:

Dear Fellow Amylin Shareholder:

As Lead Independent Director of Amylin, I am writing you today to provide a summary of exciting business developments at your company, as well as details on the slate of highly qualified and experienced individuals we nominated to serve on your Board. My fellow Board members and I are committed to transparency and principled corporate governance, and will maintain steady communications with you, our shareholders, in the weeks leading up to our 2009 annual meeting. We are proud of the company we have built, and believe that we have gained momentum to deliver strong results for our shareholders in the near and long term. We strongly believe that the election of our proposed slate of directors at the upcoming annual meeting is critical for Amylin's future success.

Recent Amylin Business Successes

If you have been following the news in recent days, you will have seen that Amylin's long-term strategy is yielding important results. We are beginning to see significant momentum to support our launch of exenatide once weekly. This investigational therapy has the potential to revolutionize the treatment of type 2 diabetes and will be a critical driver of future growth for Amylin. Under the leadership of President and Chief Executive Officer Daniel M. Bradbury and his management team, exenatide once weekly is on track for a planned launch in 2010. The steps that we have taken to enhance the commercial opportunities for our products are already beginning to yield results.

The management team continues to prepare exenati
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Chicago, IL (PRWEB) July 31, 2014 ... wave of automation across the U.S., increasing unemployment, ... middle class. It is a Catch 22—we ... internationally, but this means fewer jobs,” says economist ... the just-released Pollina Corporate Top 10 Pro-Business States ...
(Date:7/31/2014)... Sales Horizons, a leader in sales training, ... course – Mastering the Complex Sale – ... from proven sales training programs used by thousands of ... online sales training course is available to every salesperson ... with customers, like technical support, engineers, clinical support, and ...
(Date:7/30/2014)... A study presented at the 2014 ... of CSL Behring,s C1 Inhibitor (C1-INH) concentrate in ... sensitized patients. C1-INH is a human protein and ... The study shows that post-transplant treatment with ... of complement components 3 and 4, suggesting that ...
(Date:7/30/2014)... July 30, 2014 Sales Horizons, a ... of blended sales training programs for companies engaged in ... programs used by thousands of salespeople over 25 years ... training program can be customized to address the unique ... blended sales training program consists of two ...
Breaking Biology Technology:ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 2Sales Horizons Offers Mastering the Complex Sale - a Comprehensive, Online Sales Skills Training Course 3Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 2Study Suggests C1-INH May Aid in Prevention of Antibody-Mediated Rejection Following Kidney Transplant 3Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3
... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today ... upcoming Deutsche Bank 2009 Health Care Conference on Monday, May ... Boston.The live and archived webcast of the company presentation can ... Center at www.idenix.com . Please log ...
... SAN DIEGO, May 11 Neurocrine Biosciences, Inc. (Nasdaq: ... President and Chief Executive Officer of Neurocrine Biosciences will ... Care Conference in Boston. The live presentation takes place ... (ET)/2:05 p.m. Pacific Time (PT). The presentation will ...
... Neurologists to Plan Next Clinical StudiesOMAHA, Neb. and ... Board: TBIO) and Power3 Medical Products, Inc. (OTC ... the NuroPro(R) AD and NuroPro(R) PD tests for ... Academy of Neurology meeting in Seattle, WA. The ...
Cached Biology Technology:Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference 2Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 2Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 3Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 4Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting 5
(Date:7/30/2014)... POTSDAM, N.Y. , July 30, 2014 /PRNewswire/ ... of spoof mitigation and liveness detection solutions for ... FIDO Alliance, an industry consortium revolutionizing online authentication ... COO Mark Cornett , "The decision to ... help make biometric authentication pervasive in use. We ...
(Date:7/30/2014)... Long before humans figured out how to create colors, ... bright butterfly wings of many different hues, for example. ... a more environmentally friendly way to make colored plastics. ... and architectures of materials rather than dyes, to ... Letters . , N. Asger Mortensen, Anders Kristensen and ...
(Date:7/30/2014)... Bjorn Brembs, professor of neurogenetics at the Institute of ... allowing readers and reviewers to run the underlying code ... leap forward for scientific publishing, by demonstrating a completely ... output. , Figure 3 in fact doesn,t really exist. ... F1000Research , and the figure is generated ,on ...
Breaking Biology News(10 mins):NexID Biometrics Joins the FIDO Alliance 2F1000Research brings static research figures to life 2
... Chinese hybrid rice genome, which was published in the Journal ... map of the rice genome. In an article published by ... scientists led by the Beijing Institute of Genomics (BIG) reported ... japonica subspecies of O. sativa." , The fine maps of ...
... an important molecular signaling mechanism whose existence has been,known, ... since the,identification of a mutant strain of Drosophila fruit ... Later studies,revealed that the Notch gene encodes a receptor ... and which is capable of,interacting with a ligand partner, ...
... new research indicates that it may all come down ... University scientists who had previously identified a key gene ... now shows that this gene's function appears to be ... by Leslie Vosshall's laboratory had previously shown that of ...
Cached Biology News:Whole genome fine map of rice completed 2Bound for destruction: Ubiquitination protects against improper Notch signaling 2Bound for destruction: Ubiquitination protects against improper Notch signaling 3Ancient olfaction protein is shared by many bugs, offering new pest control target 2
RayBio Human Chemokine Antibody Array 1.1 (8) with Accessory, detects 38 chemokine factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
Vybrant® Multidrug Resistance Assay Kit...
... Platypus Contact Printing Kit contains choice of ... series of 100 / 200 micron squares ... 200 um x 10 mm lines, 3 ... 40 or 60 nm and pitch of ...
Request Info...
Biology Products: